

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 25 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: ONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
Levotiron provides levothyroxine sodium (T4), the standard of care for replacing deficient thyroid hormone in diagnosed hypothyroidism. When dosed and monitored correctly, T4 therapy helps restore a normal metabolic rate, energy, thermoregulation, and overall wellbeing. This is a prescription medication with an FDA boxed warning: thyroid hormones must not be used for weight loss in euthyroid individuals. Always follow your clinician's instructions.
Levothyroxine is a synthetic form of thyroxine (T4), a prohormone that peripheral tissues convert into triiodothyronine (T3), the active hormone. This design provides day-to-day stability thanks to T4's long half-life (~1 week), while letting each tissue regulate its own T3 needs. For many patients, T4 alone normalizes symptoms and labs. In select cases where symptoms persist, clinicians may consider adjustments or, occasionally, adjunct T3—always individualized.
Half-life: roughly seven days in euthyroid adults (shorter when hyperthyroid, longer when hypothyroid).
Onset: symptom improvements may begin within 1–2 weeks; full steady state is reached after several weeks due to the long half-life.
Consistency: take at the same time each day, preferably on an empty stomach with water, at least 30–60 minutes before breakfast or at bedtime (≥3–4 hours after last meal). Caffeine and certain foods/supplements can impair absorption.
Therapy is individualized based on age, weight, cardiac status, pregnancy, and etiology. Many adults start at 25–50 mcg once daily, with dose changes every 4–6 weeks until the lowest effective maintenance dose is reached. Older adults or patients with coronary disease often start 12.5–25 mcg with slower titration. In central (pituitary/hypothalamic) hypothyroidism, TSH is unreliable—clinicians use FT4 (and sometimes T3) plus symptoms.
Authoritative labeling (indications, boxed warning, dosing principles, interactions) is available in FDA prescribing information for levothyroxine products, e.g., the Levothyroxine Sodium Tablets FDA label.
Levothyroxine's intestinal absorption is sensitive to timing. Separate your dose from: iron, calcium, aluminum/magnesium antacids, bile acid resins, sucralfate, phosphate binders, high-fiber or soy-heavy meals, and certain coffees by several hours. Changes in estrogen therapy, GI conditions (e.g., celiac disease), and enzyme inducers can alter dose requirements. Anticoagulants and antidiabetics may need review after thyroid dose changes. Share your full medication/supplement list with your clinician.
T4 is not a shortcut for fat loss. For performance populations with diagnosed hypothyroidism, restoring euthyroid status supports healthy metabolism, recovery, and training capacity. Intelligent programming still matters: adequate calories and protein, progressive overload, sleep hygiene, and stress management. In advanced recomposition blocks, clinicians sometimes address cardiometabolic factors (lipids, BP, glucose control) alongside thyroid therapy.
This listing is for Abdi İbrahim Levotiron 25 mcg tablets (50 count). Store at room temperature, away from moisture, heat, and light. Keep out of reach of children. Use only if prescribed and sourced legally in your jurisdiction.
Medical disclaimer: For informational purposes only; not medical advice. Follow your licensed clinician's guidance for dosing, monitoring, and duration.
No. Thyroid hormones carry an FDA boxed warning and must not be used for obesity or weight loss in euthyroid patients. Levotiron is for diagnosed thyroid conditions under medical supervision.
Many adults start at 25–50 mcg once daily; older adults/cardiac patients often begin at 12.5–25 mcg. Clinicians adjust every 4–6 weeks based on symptoms and labs to reach the lowest effective dose.
Take on an empty stomach with water at the same time daily—30–60 minutes before breakfast or at bedtime (3–4 hours after the last meal). Separate from iron, calcium, antacids, and high-fiber/soy foods by several hours.
Under-replacement: fatigue, cold intolerance, constipation, dry skin/hair. Over-replacement: palpitations, tremor, heat intolerance, anxiety, insomnia, weight loss. Report symptoms so your clinician can adjust your dose.
T4 (levothyroxine) is a prohormone converted to T3 in tissues. Most patients do well on T4 alone. In select cases, clinicians consider adjunct T3, but this is individualized and guided by labs and symptoms.
Please log in to write LEVOTIRON 25 MCG review.
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 200 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 125 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 75 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 175 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 150 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 50 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 100 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE
ACTIVE SUBSTANCE: LIOTHYRONINE SODIUM
FORM: 100 TABLETS x 25 MCG
ACTIVE HALF-LIFE: 1 DAY
DOSAGE: MEN 25-75 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): YES
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS